Related Experiment Video
Updated: Mar 19, 2026

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
Clinical and Laboratory Findings in Patients with δ-Storage Pool Disease: A Case Series
Fabien Selle1, Chloé James1, Marie Tuffigo1
1Université de Bordeaux, Bordeaux, France.
Insights
Platelet δ-storage pool disease (δ-SPD) is a rare platelet disorder affecting dense granules. This study reveals GPIb-impaired mobilization as a potential additional feature, complicating diagnosis.
Area of Science:
- Hematology
- Platelet Physiology
- Genetic Blood Disorders
Background:
- Platelet δ-storage pool disease (δ-SPD) is characterized by deficient dense granules, impacting platelet function.
- Existing literature primarily consists of case reports, limiting comprehensive understanding of δ-SPD.
- This study retrospectively analyzes a cohort of 16 patients to better define δ-SPD characteristics.
Observation:
- Patients presented with mild to moderate bleeding diathesis.
- Platelet aggregation showed variable abnormalities, with a consistent near-complete absence of ATP release.
- Dense granule content and ultrastructure varied, allowing for subtype classification (quantitative vs. qualitative defects).
Findings:
- Dense granule deficiency is the hallmark of δ-SPD.
- Subtypes of δ-SPD can be distinguished by quantitative or qualitative dense granule defects.
- A novel finding is significantly decreased GPIb expression upon activation, suggesting impaired GPIb mobilization.
Implications:
- δ-SPD is a complex disorder with diverse clinical and biological manifestations.
- Impaired GPIb mobilization may be an underrecognized aspect of δ-SPD.
- Accurate diagnosis of δ-SPD requires specialized expertise and comprehensive testing.
Abstract:
Platelet δ-storage pool disease (δ-SPD) is a platelet function disorder characterized by a reduction in the number or content of dense granules. Reports on δ-SPD are mostly limited to case presentations. We aimed to retrospectively describe a series of patients with δ-SPD to better characterize the disease. We studied 16 patients with congenital or acquired δ-SPD. Lumiaggregometry, α- and δ-granules content, platelet ultrastructure, αIIbβ3 integrin, and glycoprotein Ib (GPIb) activation were assessed. Most of the patients generally demonstrate mild to moderate bleeding diathesis. Platelet aggregation studies showed moderate abnormalities with variable profiles, while all the individuals had almost complete absence of adenosine triphosphate release. Mepacrine capture, CD63 expression, and study of dense granules by electron microscopy enabled to distinguish different subtypes of δ-SPD with quantitative or qualitative defect. Surprisingly, significantly decreased GPIb expression levels after platelet activation with thrombin receptor activating peptide 50 μM were found, suggesting that GPIb-impaired mobilization may represent an additional feature of the disorder. In conclusion, δ-SPD represents a complex disorder with various clinical and biological aspects, requiring a great deal of expertise to be properly diagnosed.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests

